SG11201401460PA - POLYMORPHS OF ARRY-380, A SELECTIVE ErbB2 (HER2) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
POLYMORPHS OF ARRY-380, A SELECTIVE ErbB2 (HER2) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- SG11201401460PA SG11201401460PA SG11201401460PA SG11201401460PA SG11201401460PA SG 11201401460P A SG11201401460P A SG 11201401460PA SG 11201401460P A SG11201401460P A SG 11201401460PA SG 11201401460P A SG11201401460P A SG 11201401460PA SG 11201401460P A SG11201401460P A SG 11201401460PA
- Authority
- SG
- Singapore
- Prior art keywords
- arry
- polymorphs
- her2
- inhibitor
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161547615P | 2011-10-14 | 2011-10-14 | |
| US201261606185P | 2012-03-02 | 2012-03-02 | |
| PCT/US2012/060138 WO2013056183A1 (en) | 2011-10-14 | 2012-10-12 | Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions contianing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201401460PA true SG11201401460PA (en) | 2014-09-26 |
Family
ID=47471982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401460PA SG11201401460PA (en) | 2011-10-14 | 2012-10-12 | POLYMORPHS OF ARRY-380, A SELECTIVE ErbB2 (HER2) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Country Status (17)
| Country | Link |
|---|---|
| US (6) | US9168254B2 (zh) |
| EP (1) | EP2766363A1 (zh) |
| JP (4) | JP2014530243A (zh) |
| KR (2) | KR102061917B1 (zh) |
| CN (1) | CN104011047A (zh) |
| AU (1) | AU2012323890A1 (zh) |
| BR (1) | BR112014009084B1 (zh) |
| CA (1) | CA2852060A1 (zh) |
| CL (1) | CL2014000932A1 (zh) |
| CO (1) | CO6960548A2 (zh) |
| CR (1) | CR20140219A (zh) |
| IL (1) | IL232062A0 (zh) |
| MX (2) | MX370680B (zh) |
| RU (1) | RU2629116C2 (zh) |
| SG (1) | SG11201401460PA (zh) |
| UA (1) | UA116875C2 (zh) |
| WO (1) | WO2013056183A1 (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201401460PA (en) | 2011-10-14 | 2014-09-26 | Array Biopharma Inc | POLYMORPHS OF ARRY-380, A SELECTIVE ErbB2 (HER2) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US9457093B2 (en) | 2011-10-14 | 2016-10-04 | Array Biopharma Inc. | Solid dispersions of a ERB2 (HER2) inhibitor |
| AU2013234921A1 (en) | 2012-03-23 | 2014-10-02 | Array Biopharma Inc. | Treatment of brain cancer |
| CN110446495B (zh) | 2017-02-17 | 2023-09-05 | 特维娜有限公司 | 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法 |
| US11207324B2 (en) | 2017-04-28 | 2021-12-28 | Seagen Inc. | Treatment of HER2 positive cancers |
| US20220040324A1 (en) | 2018-12-21 | 2022-02-10 | Daiichi Sankyo Company, Limited | Combination of antibody-drug conjugate and kinase inhibitor |
| CN109942576B (zh) * | 2019-03-07 | 2020-09-11 | 上海工程技术大学 | Irbinitinib及中间体的制备方法 |
| EP3947367A1 (en) | 2019-04-02 | 2022-02-09 | Array Biopharma, Inc. | Protein tyrosine phosphatase inhibitors |
| CA3156820A1 (en) | 2019-10-21 | 2021-04-29 | Seagen Inc. | Methods of treating her2 positive breast cancer with tucatinib in combination with capecitabine and trastuzumab |
| KR20220115566A (ko) | 2019-11-15 | 2022-08-17 | 시아겐 인크. | 항-her2 항체-약물 접합체와 조합된 투카티닙으로 her2 양성 유방암을 치료하는 방법 |
| CA3183592A1 (en) | 2020-05-29 | 2021-12-02 | Seagen Inc. | Methods of treating her2 positive cancer with tucatinib in combination with trastuzumab and an oxaliplatin-based chemotherapy |
| KR20230047359A (ko) | 2020-07-29 | 2023-04-07 | 시아겐 인크. | 트라스투주맙, 탁산 및 vegfr-2 길항제와 병용하여 투카티닙을 이용하는 her2 양성 암의 치료 방법 |
| WO2022093904A1 (en) * | 2020-10-27 | 2022-05-05 | Trevena, Inc. | Crystalline and amorphous forms of a delta-opioid modulator |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9514464D0 (en) | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
| ES2549159T3 (es) | 2002-03-13 | 2015-10-23 | Array Biopharma, Inc. | Derivados de bencimidazol N3-alquilados como inhibidores de MEK |
| CN102432552B (zh) | 2003-08-14 | 2016-01-20 | 阿雷生物药品公司 | 作为受体酪氨酸激酶抑制剂的喹唑啉类似物 |
| US7501427B2 (en) | 2003-08-14 | 2009-03-10 | Array Biopharma, Inc. | Quinazoline analogs as receptor tyrosine kinase inhibitors |
| JP2007505873A (ja) | 2003-09-16 | 2007-03-15 | アストラゼネカ アクチボラグ | チロシンキナーゼ阻害剤としてのキナゾリン誘導体 |
| GB0321648D0 (en) | 2003-09-16 | 2003-10-15 | Astrazeneca Ab | Quinazoline derivatives |
| ES2364901T3 (es) * | 2005-11-15 | 2011-09-16 | Array Biopharma, Inc. | Procesos e intermedios para la preparación de derivados de n4-fenil-quinazolin-4-amina. |
| SG11201401460PA (en) | 2011-10-14 | 2014-09-26 | Array Biopharma Inc | POLYMORPHS OF ARRY-380, A SELECTIVE ErbB2 (HER2) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US9457093B2 (en) | 2011-10-14 | 2016-10-04 | Array Biopharma Inc. | Solid dispersions of a ERB2 (HER2) inhibitor |
| AU2013234921A1 (en) | 2012-03-23 | 2014-10-02 | Array Biopharma Inc. | Treatment of brain cancer |
-
2012
- 2012-10-12 SG SG11201401460PA patent/SG11201401460PA/en unknown
- 2012-10-12 MX MX2014004553A patent/MX370680B/es active IP Right Grant
- 2012-10-12 UA UAA201405086A patent/UA116875C2/uk unknown
- 2012-10-12 WO PCT/US2012/060138 patent/WO2013056183A1/en active Application Filing
- 2012-10-12 CN CN201280061944.9A patent/CN104011047A/zh active Pending
- 2012-10-12 BR BR112014009084-0A patent/BR112014009084B1/pt active IP Right Grant
- 2012-10-12 EP EP12809374.7A patent/EP2766363A1/en not_active Withdrawn
- 2012-10-12 AU AU2012323890A patent/AU2012323890A1/en not_active Abandoned
- 2012-10-12 KR KR1020147012994A patent/KR102061917B1/ko active IP Right Grant
- 2012-10-12 KR KR1020197038192A patent/KR20200003245A/ko not_active Application Discontinuation
- 2012-10-12 RU RU2014119269A patent/RU2629116C2/ru active
- 2012-10-12 US US14/351,835 patent/US9168254B2/en active Active
- 2012-10-12 CA CA2852060A patent/CA2852060A1/en not_active Abandoned
- 2012-10-12 JP JP2014535963A patent/JP2014530243A/ja active Pending
-
2014
- 2014-04-10 IL IL232062A patent/IL232062A0/en unknown
- 2014-04-11 CL CL2014000932A patent/CL2014000932A1/es unknown
- 2014-04-14 MX MX2019010083A patent/MX2019010083A/es unknown
- 2014-05-12 CR CR20140219A patent/CR20140219A/es unknown
- 2014-05-14 CO CO14103945A patent/CO6960548A2/es unknown
-
2015
- 2015-10-26 US US14/923,172 patent/US9889134B2/en active Active
- 2015-12-04 JP JP2015237564A patent/JP2016033166A/ja active Pending
-
2017
- 2017-05-01 JP JP2017091106A patent/JP2017128612A/ja active Pending
-
2018
- 2018-01-03 US US15/861,444 patent/US10143692B2/en active Active
- 2018-08-27 JP JP2018158534A patent/JP2018177822A/ja active Pending
- 2018-10-24 US US16/169,937 patent/US10765678B2/en active Active
-
2020
- 2020-07-29 US US16/942,094 patent/US11571424B2/en active Active
-
2023
- 2023-01-03 US US18/092,731 patent/US20230241066A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201401460PA (en) | POLYMORPHS OF ARRY-380, A SELECTIVE ErbB2 (HER2) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| ZA201606123B (en) | Pharmaceutical compositions of a erb2 (her2) inhibitor | |
| IL230218A (en) | Converted atherothecyclic compounds, their preparations and their pharmaceutical preparations | |
| HK1199726A1 (zh) | 犬尿氨酸- -單加氧酶抑制劑、其藥物組合物及其使用方法 | |
| AP3864A (en) | Pharmaceutical composition | |
| GB201113662D0 (en) | Pharmaceutical compositions | |
| HK1198619A1 (zh) | 某些犬尿氨酸- -單加氧酶抑制劑、其藥物組合物及其使用方法 | |
| ZA201308208B (en) | Pharmaceutical compositions | |
| HK1199705A1 (zh) | 犬尿氨酸- -單加氧酶抑制劑、藥物組合物及其使用方法 | |
| HK1199824A1 (zh) | 藥物組合物 | |
| EP2702054A4 (en) | NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM, AND USE THEREOF | |
| IL231383A0 (en) | History of imidazole amines, their preparation and pharmaceutical preparations containing them | |
| IL232577A0 (en) | The history of morpholinylbenzotriazine, their preparation and pharmaceutical preparations containing them | |
| ZA201307593B (en) | Antihypertensive pharmaceutical composition | |
| ZA201307094B (en) | Fluorescent whitening agent compositions | |
| IL230219A0 (en) | History of dihydropyrazole, their preparation and pharmaceutical preparations containing them | |
| AP2012006280A0 (en) | Synthesis process, and crystalline form of 4-ä3-ÄCis-hexahydrocyclopentaÄCÜpyrrol-2(1H)-YLÜpropoxyübenzamide hydrochloride and pharmaceutical compositions containing it. | |
| EP2742946A4 (en) | PROCESS FOR THE PRODUCTION OF PYROSTEGIA VENUSTA DERIVATIVES, PYROSTEGIA VENUSTA DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
| GB201118181D0 (en) | Pharmaceutical compositions | |
| ZA201404711B (en) | Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives | |
| AP3344A (en) | New dihydro-oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA201106353B (en) | Dihydrobenzoxathiazepine compounds,a process for their preparation and pharmaceutical compositions containing them | |
| GB201100786D0 (en) | Pharmaceutical compositions of immunosuppressants | |
| GB201407689D0 (en) | Pharmaceutical compositions of antihypertensives | |
| EP2714715A4 (en) | PHARMACEUTICAL COMPOSITIONS |